• SENSEX 81,463.09
    -721.08 (--0.88%)
  • BANKNIFTY 56,528.90
    -537.15 (--0.94%)
  • Authum Invest
    2,250.00 985.45(%)
  • Indian Energy Ex
    149.45 244.35(%)
  • Vimta Labs
    598.90 598.90(%)
  • Bharti Airtel
    1,952.40 2,045.50(%)
  • Force Motors
    16,488.00 6,128.55(%)
  • Bajaj Finance
    897.65 642.61(%)
  • Anant Raj
    606.00 947.25(%)
  • Jayaswal Neco
    40.05 26.06(%)
  • Sharda Cropchem
    1,090.25 1,090.25(%)
  • Infosys
    1,511.35 1,307.10(%)
  • Olectra Greentec
    1,460.00 973.65(%)
  • Tata Motors
    685.00 542.55(%)
  • Eternal Ltd
    306.25 189.60(%)
  • Trent
    5,033.80 4,491.75(%)
  • Reliance Industr
    1,384.50 1,115.55(%)
  • Waaree Energies
    3,171.00 1,808.65(%)
  • Phoenix Mills
    1,545.00 1,965.00(%)
  • Kajaria Ceramics
    1,151.00 745.00(%)
  • Adani Green
    972.75 758.00(%)
  • Cipla
    1,553.00 1,702.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Solara Active Pharma Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 70281.0
  • ISIN : INE624Z01016
697.00 40 (6.06%)
  • As on 26 Jul 2025 (EOD)
  • Today’s Low

    637.85
  • Today’s High

    734.40
  • Open

    655.00
  • Perv Close

    657.20
  • 52W Low

    442.80
  • 52W High

    882.80

Key Indicators

  • P/E(TTM)

    115.58

  • Mar.Cap (₹Cr.)

    3,059.62

  • Div & Yield %

    0.00

  • Book Value(₹)

    302.07

  • Debt-Equity Ratio

    6.06

  • AGM Date

    25-Jul-2025

  • EPS

    6.02

  • P/E Ratio

    115.58

Financials Ratios

  • Debt-Equity Ratio

    0.83

  • Mar.Cap (₹Cr.)

    3,059.62

  • RONW (%)

    0.00

  • ROCE (%)

    0.00

Score Board

  • Equity (₹ in Cr.)

    36.15

  • BV (₹)

    302.10

  • Sales( ₹ in Cr.)

    1,283.76

  • NP (in Cr.)

    -1.08

  • NP Var(%)

    100.0

  • Div%

    0.0

  • CPS (₹)

    27.20

  • EPS (₹)

    -0.30

  • Traded Value (₹ in Lakhs)

    3,055.90

  • 52 Week High

    882.80

  • 52 Week Low

    442.80

  • Price BSE

    696.0

  • Price NSE

    697.00

  • Market Capital( in Cr.)

    3,055.90

  • P/C Ratio

    25.60

  • P/E Ratio

    -2,329.90

  • Price Vs.BV

    -0.30

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 1,288.92 1,443.81 1,268.34 1,616.88 1,321.75 1,386.68
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 1,288.92 1,443.81 1,268.34 1,616.88 1,321.75 1,386.68
Other Income 5.37 22.14 18.76 28.41 27.51 12.03
Stock Adjustments -39.27 -7.05 258.75 2.15 54.16 33.79
Total Income 1,255.02 1,458.90 1,545.85 1,647.44 1,403.42 1,432.50
EXPENDITURE :            
Raw Materials 765.75 781.78 912.64 726.56 653.03 738.62
Power and Fuel Cost 122.56 107.95 93.70 85.42 77.68 79.35
Employee Cost 243.92 228.05 234.20 227.63 202.24 183.98
Other Manufacturing Expenses 109.31 90.76 97.87 91.19 89.50 91.58
Selling and Administration Expenses 70.40 67.50 76.39 76.07 74.19 64.70
Miscellaneous Expenses 222.41 26.68 35.43 26.83 22.74 48.38
Employee Benefit Expenses 243.92 228.05 234.20 227.63 202.24 183.98
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,534.35 1,302.72 1,450.23 1,233.70 1,119.38 1,206.61
Operating Profit -279.33 156.18 95.62 413.74 284.04 225.89
Interest 105.97 90.06 75.27 84.47 77.88 82.42
Gross Profit -385.30 66.12 20.35 329.27 206.16 143.47
Depreciation 103.03 110.90 112.01 108.31 93.67 82.79
Profit Before Tax -488.33 -44.78 -91.66 220.96 112.49 60.68
Current Tax 0.00 -0.11 0.00 38.64 20.69 15.96
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 78.54 -22.46 -33.10 -38.64 -20.69 -13.95
Reported Net Profit -566.87 -22.21 -58.56 220.96 112.49 58.67
Extraordinary Items -158.84 -0.45 -4.26 1.65 -0.26 0.32
Adjusted Net Profit -408.03 -21.76 -54.30 219.31 112.75 58.35
Adjustment below Net Profit 0.56 -1.76 2.01 -2.53 -3.85 -10.70
P & L Balance brought forward 250.04 274.01 341.34 142.65 49.67 1.70
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 10.78 19.74 15.66 0.00
P & L Balance carried down -316.27 250.04 274.01 341.34 142.65 49.67
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 30.00 0.00 70.00 20.00 50.00
Dividend Per Share(Rs) 0.00 3.00 0.00 7.00 2.00 5.00
Earnings Per Share-Unit Curr -157.46 -6.17 -16.27 61.50 41.90 22.77
Earnings Per Share(Adj)-Unit Curr -145.12 -5.69 -15.00 56.68 38.62 20.99
Book Value 260.39 417.54 424.18 443.30 370.50 333.12
Book Value(Adj)-Unit Curr 239.98 384.83 390.94 408.56 341.46 307.01

Shareholding Pattern

  • Promoter Group

    42.01%

  • Public Share Holding

    57.99%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 3,401,417 7.06 3,401,417 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 16,829,864 34.95 16,829,864 9
Sub Total 20,231,281 42.01 20,231,281 20
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,354 0.00 1,354 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 1,308 0.00 1,308 4
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 6,863,162 14.25 6,863,162 53
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 567,336 1.18 567,336 3
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 694,050 1.44 694,050 6
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 8,127,210 16.88 8,127,210 67
2] Non Institution
Bodies Corporate 4,039,766 8.39 4,039,327 483
Clearing Members 77 0.00 77 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 581,556 1.21 580,243 1,562
Foreign Non Institution Other 1,258,649 2.61 1,258,649 2
Hindu Undivided Families 557,238 1.16 557,145 1,558
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 2,717,304 5.64 2,717,304 46
Individuals holding nominal share capital up to Rs. 1 lakh 8,585,832 17.83 8,563,293 70,528
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 13,031 0.03 13,031 4
Others 17,790 0.04 17,790 3
Sub Total 19,794,531 41.11 19,770,147 74,247
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 48,153,022 100.00 48,128,638 74,334

Company Background

Solara Active Pharma Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Solara Active Pharma Sciences Ltd
  • BSE Code : 70281.0
  • ISIN : INE624Z01016
  • Incorporation Year

    2017

  • Registered Office

    201 Devavrata Sector 17 Vashi
    Navi Mumbai, Mumbai,
    Maharashtra-400703

  • Telephone

    91-22-27892924

  • FAX

    91-22-27892942

  • Chairman

    RAJAGOPALAN RAMAKRISHNAN

  • Managing Director

    Sandeep Rao

  • Company Secretary

    Pooja Jaya Kumar

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    Cameo Corporate Services Ltd
    Subramanian Building,
    1ST Floor No 1,Club House Road
    Mumbai - Chennai - 600002

Solara Active Pharma Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Solara Active 695.80 1,294.29 1,288.92 115.58 0.00
Abbott India 33,771.20 6,684.73 6,409.15 50.74 44.95
Astrazeneca Phar 8,832.65 1,756.92 1,716.29 190.77 32.94
P & G Health Ltd 5,831.90 1,166.89 1,151.26 38.54 39.76
Glaxosmi. Pharma 3,154.75 3,866.05 3,723.49 58.15 58.72
Cipla 1,531.10 20,029.57 19,044.85 23.98 21.40
Amrutanjan Healt 679.00 437.58 421.23 38.62 20.84
Fermenta Biotec. 375.35 442.21 430.53 16.34 17.61
Guj. Themis Bio. 363.35 174.19 169.82 81.10 44.82
Bliss GVS Pharma 153.45 703.42 667.20 23.46 9.16
Ambalal Sarabhai 32.88 19.33 4.04 30.44 2.10